GIACOMELLI, ANDREA
GIACOMELLI, ANDREA
Dipartimento di Scienze Biomediche e Cliniche
Re-emergence of Mpox associated with a distinct MPXV clade: implications for public health and stigma mitigation
2024 A. Rizzo, A. Giacomelli, D. Moschese, D. Mileto
Rilpivirine and cabotegravir trough concentrations in people with HIV on long-term treatment with long-acting injectable antiretrovirals
2024 M. Vittoria Cossu, D. Cattaneo, D. Moschese, A. Giacomelli, S. Soloperto, A. D’Avolio, S. Antinori, A. Gori, G. Rizzardini, C. Gervasoni
Management of enzyme de-induction in a woman with HIV on methadone maintenance switched from nevirapine- to bictegravir-based antiretroviral regimen
2024 D. Cattaneo, A. Giacomelli, G. Casalini, A.L. Ridolfo, C. Gervasoni
Risk of virological failure after drug burden reduction in people with 4-class drug-resistant HIV on virological suppression: A retrospective cohort analysis of data from the PRESTIGIO Registry
2024 T. Clemente, S. Diotallevi, R. Lolatto, R. Gagliardini, A. Giacomelli, M. Fiscon, M. Ferrara, A. Cervo, L. Calza, F. Maggiolo, S. Rusconi, M.M. Santoro, A. Castagna, V. Spagnuolo
Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024
2024 D. Moschese, A. Roberto Raccagni, A. Giacomelli, A. Piralla, R. Rossotti, A. Raimondi, D. Tesoro, L. Vezzosi, M. Gulletta, N. Clementi, S. Venturelli, S. Benardon, D. Ricaboni, D. Bernacchia, A. Mancon, F. Rovida, F. Attanasi, D. Cereda, M.R. Gismondo, A. Gori, G. Rizzardini, S. Antinori, F. Baldanti, A.V. Marzano, G. Marchetti, F. Castelli, A. Castagna, S. Nozza, D. Mileto, P. Bonfanti, L. Biasioli, R. Bruno, M. Vittoria Cossu, C. Fusetti, S. Lazzarin, M. Locatelli, M. Morosi, M. Piscaglia, L. Pusterla, G. Pozza, S. Ramoni, S. Rusconi, M. Rizzi, A. Rizzo, F. Sabaini, F. Salari, M. Sampaolo, M. Puoti, M. Tirani, L. Rachele Tomasoni
High prevalence of high-risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy
2024 A. Rizzo, D. Moschese, F. Salari, A. Giacomelli, L. Morelli, M.V. Cossu, C. Fusetti, F. Petri, G. Casalini, A. Poloni, S. Lazzarin, A. Gori, S. Antinori, M.R. Gismondo, A. Lombardi, G. Rizzardini
Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis – results from the ICONA cohort in Italy, 2009-2022
2024 A. Mondi, A. Cozzi-Lepri, A. Tavelli, A. Cingolani, A. Giacomelli, G. Orofino, G. De Girolamo, C. Pinnetti, A. Gori, A. Saracino, A. Bandera, G. Marchetti, E. Girardi, C. Mussini, A. d'Arminio Monforte, A. Antinori
Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV
2024 M.V. Cossu, A. D'Avolio, C. Gervasoni, A. Giacomelli, D. Cattaneo, D. Moschese
COVID-19: Find the Right Questions to be Answered
2024 A. Giacomelli, S. Antinori, A. Gori, A. Cozzi-Lepri
Evaluation of analytical performance of the STANDARDTM M10 MPX/OPX assay for the simultaneous DNA detection and clade attribution of Monkeypox virus
2024 A. Mancon, A.R. Raccagni, G. Gagliardi, D. Moschese, A. Rizzo, A. Giacomelli, M. Cutrera, F. Salari, F. Bracchitta, S. Antinori, A. Gori, G. Rizzardini, A. Castagna, M.R. Gismondo, S. Nozza, D. Mileto
Mismanagement of SARS-CoV-2 Infection Pre Hospitalisation during the Omicron Era: Antibiotics and Steroids Instead of Early Antivirals
2024 A. Giacomelli, C.L. Ciubotariu, M. Zacheo, A. Rabbione, M. Pieruzzi, F. Barone, A. Poloni, G. Casalini, G. Pozza, M. Colaneri, M. Passerini, A. Lisa Ridolfo, C. Gervasoni, D. Cattaneo, A. Gori, S. Antinori
Response to the Letter to the Editor Regarding “Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study”
2024 M. Canuti, F. Fassio, C. Genovese, A. Giacomelli, A.L. Ridolfo, E. Asperges, G. Albi, R. Bruno, S. Antinori, A. Muscatello, B. Mariani, C. Canetta, F. Blasi, A. Bandera, A. Gori, M. Colaneri
The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation
2024 G. Casalini, A. Giacomelli, S. Antinori
How to manage adult patients with malaria in the non-endemic setting
2024 S. Antinori, A. Giacomelli, G. Casalini, A.L. Ridolfo
Different effects of the companion antiretroviral drugs on dolutegravir trough concentrations
2024 D. Cattaneo, S. Pagano, M.L. Colombo, A. Giacomelli, A. Gori, C. Gervasoni
Impact of a Bundle of Interventions on Quality-of-Care Indicators for Staphylococcus aureus Bacteraemia: A Single-Centre, Quasi-Experimental, Before–After Study
2024 G. Casalini, C. Pagani, A. Giacomelli, L. Galimberti, L. Milazzo, M. Coen, S. Reato, B. Caloni, S. Caronni, S. Pagano, S. Lazzarin, A. Lisa Ridolfo, S. Giordana Rimoldi, A. Gori, S. Antinori
Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort
2024 A. Ciccullo, G. Baldin, A. Cervo, D. Moschese, F. Lagi, M.V. Cossu, A. Grimaldi, A. Giacomelli, S. Rusconi, G. Sterrantino, A. Borghetti, S. Antinori, C. Mussini, S. Di Giambenedetto
Prevalence of extracardiac vascular complications in Abiotrophia spp. and Granulicatella spp. infective endocarditis: Two case reports and a systematic review
2024 G. Pozza, C. Mariani, M. Passerini, M. Colaneri, A. Giacomelli, L.J. Prokop, M.H. Murad, M. Schiavini, A. Gori, S. Antinori
Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study
2024 M. Colaneri, C. Genovese, F. Fassio, M. Canuti, A. Giacomelli, A.L. Ridolfo, E. Asperges, G. Albi, R. Bruno, S. Antinori, A. Muscatello, B. Mariani, C. Canetta, F. Blasi, A. Bandera, A. Gori
Comment on: Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients
2024 F. Barone, A. Giacomelli, G. Casalini, M. Corbellino, A. Lai, A. Gori, S. Antinori